If you had lower telomerase activity, then you had a higher risk of Type2 Diabetes and all the changes associated with getting fat.
According to this study published by the Karolinska Institute in Stockholm in JAMA Neurology this week, there is a statistical association between Alzheimer’s disease and shorter telomeres via the single nucleotide polymorphisms associated with telomere shortening.
Well, the FDA just informed the company to stop because of lack of “scientific evidence” so that has saved me from doing any diligence on this test, which I must admit didn’t feel like it was really due much anyway.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
